Pruvanserin hydrochloride,
443144-27-2,
EMD 281014 hydrochloride,
Pruvanserin HCl,
UNII-AWA682DH9Z,
AWA682DH9Z,
Pruvanserin hydrochloride [USAN],
Pruvanserin hydrochloride (USAN),
LY 2422347,
EMD-281014 hydrochloride,
SCHEMBL678953,
CHEMBL2104980,
DTXSID00196134,
LY2422347 HCl,
UYGNZRVLPYZLTF-UHFFFAOYSA-N,
AKOS024458175,
LSN2420586,
LSN-2420586,
D06633,
7-(4-(2-(4-Fluorophenyl)ethyl)piperazine-1-carbonyl)-1H-indole-3-carbonitrile, monohydrochloride,
7-(4-(2-(4-Fluorophenyl)ethyl)piperazine-1-ylcarbonyl)-1H-indole-3-carbonitrile hydrochloride,
7-[[4-[2-(4-Fluorophenyl)ethyl]-1-piperazinyl]carbonyl]-1H-indole-3-carbonitrile hydrochloride,
7-{4-[2-(4-fluorophenyl)ethyl]-piperazine-1-carbonyl}-1H-indole-3-carbonitrile, hydrochloride,
Piperazine, 1-((3-cyano-1H-indol-7-yl)carbonyl)-4-(2-(4-fluorophenyl)ethyl)-, monohydrochloride,
443144-27-2 (Pruvanserin HCl),
CID9887933,
B5610,
7-[4-[2-(4-fluorophenyl)ethyl]piperazine-1-carbonyl]-1H-indole-3-carbonitrile Hydrochloride,